MarketsandMarkets Biomarker and Companion Diagnostics Conference - EU Edition

1. MARKETSANDMARKETS BIOMARKER AND COMPANION DIAGNOSTICS CONFERENCE - EU EDITION 5th -6th October 2023 | Frankfurt, Germany Discovering the latest technologies and biomarkers that drive translational research and precision medicine

2. MARKETSANDMARKETS Biomarker and Companion Diagnostics Conference-EU Edition Event Overview After our successful Biomarker editions across the globe, MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 5th-6th October 2023 in Frankfurt, Germany exclusively for the EU region. This conference unites advances in biomarker use for drug discovery and development, alongside clinical translation of biomarkers. The Expert Panel will take you through their case study-based presentations which will include problems, solutions and services in the Clinical Applications of Biomarkers in Oncology, Neurology, Infectious Diseases and Rare Diseases. Our Day 2 would majorly highlight the case studies on commercialization of CDx. Attendees would evidence the examples and the case studies which will help in creating the revenue. The keynote presentations would also help the attendees understand the European regulatory and reimbursement strategies on Biomarker and CDx. For more information please contact events@marketsandmarkets.com | +91 20 48598 285 2 2

3. MARKETSANDMARKETS Biomarker and Companion Diagnostics Conference-EU Edition Key Highlights • Biomarkers in drug development and clinical trials • Biomarker qualification and validation • Precision medicine and personalized biomarkers • Biomarkers in specific diseases: Oncology, Neurology, Infectious Diseases, Rare Diseases • Biomarker data analysis and integration • CDx implementation and integration for treatment optimization • Collaboration and Partnerships in CDx development and commercialization • CDx in oncology Why to Attend • Hear from and meet with the key industry and academic innovators in biomarkers, translational medicine, clinical development, and diagnostics. • Discover the latest integration of biomarkers in early drug development through case studies by major pharma on multiple therapeutic areas, including immuno-oncology, neuroscience, cardiology, immunology respiratory rare diseases, and cell and gene therapies`. • Gain novel insights into key biomarkers for detection, monitoring, and diagnosis, including innovative applications of digital markers. • Benefit from case studies on topical technology innovation within digital pathology, AI & imaging, flow cytometry, multiplexing, mass spectrometry and spatial biology tools. • Unparalleled networking opportunities. The two-day congress offers an interactive platform for high-level scientific and business discussions. Participate in formal or informal discussions during our networking breaks and pre-organised 1-2-1 meetings. For more information please contact events@marketsandmarkets.com | +91 20 48598 285 3 3

4. MARKETSANDMARKETS Biomarker and Companion Diagnostics Conference-EU Edition Who should Attend? Researchers, scientists, clinicians, academicians and professionals from pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in: • Biomarker discovery/ development • Translational research • Clinical Biomarker • Biomarkers in IO and Neurological disorders • Imaging Biomarkers • Pathology • Companion Diagnostics • Biomarker Imaging • Proteomics Biomarkers • Experimental Medicine • Data Science • Biomarkers in Clinical Discovery • Immuno-oncology/ Neuroscience Drug Discovery • Diagnostic Biomarkers development • Personalized Medicine • Immunology Biomarkers For more information please contact events@marketsandmarkets.com | +91 20 48598 285 events@marketsandmarkets.com | +91 20 48598 285 For more information please contact 4 4 4

5. MARKETSANDMARKETS Biomarker and Companion Diagnostics Conference-EU Edition Gold Sponsor: Exhibition Partner: For more information please contact events@marketsandmarkets.com | +91 20 48598 285 5

6. MARKETSANDMARKETS Biomarker and Companion Diagnostics Conference-EU Edition Speakers: Elizabeth Sheppard Global Pricing & Market Access Director, Oncology Diagnostics, AstraZeneca, UK Patrick Brossard Director Clinical Pharmacology, Sobi - Swedish Orphan Biovitrum AB, Switzerland Eike Staub Head of Oncology Data Science, Merck Healthcare KGaA, Germany Philip Beer Chief Scientific Officer, Step Pharma, UK Jürgen Scheuenpflug Global Head Clinical Biomarkers & Companion Diagnostics, Merck Healthcare KGaA, Germany Thomas Hach Executive Director Patient Engagement, Cardiovascular, Renal & Metabolism Patient Engagement, Novartis, Switzerland For more information please contact events@marketsandmarkets.com | +91 20 48598 285 events@marketsandmarkets.com | +91 20 48598 285 For more information please contact 6 6

7. ABOUT MARKETSANDMARKETS MarketsandMarkets Events is a wholly owned division of MarketsandMarkets a global market research and intelligence company producing over 1200 premium market research reports every year across 12 different industry verticals. By bringing together expert speakers from across the world and leading technology and service providers Events provide a senior level educational and networking platform where knowledge is shared and partnerships and collaborations can be formed. With offices in Asia Europe and USA MarketsandMarkets ensures a truly global attendance at every event where attendees speakers exhibitors and sponsors can exchange ideas in a relaxed and professional environment. +91 20 48598 285 | +44 (0)1865-842-976 events@marketsandmarkets.com www.marketsandmarkets.com